Skip to content
TrustList
O2h Ventures logo
Investor

O2h Ventures

UK EIS and SEIS funds investing in early-stage biotech therapeutics and related AI

O2h Ventures cover

About O2h Ventures

O2h Ventures runs UK tax-advantaged funds that invest in biotech and life-science companies. Its funds use the EIS and SEIS tax schemes, so they suit UK taxpayers who qualify for those reliefs. The firm warns that investors could lose all of what they put in.

What O2h Ventures offers

  • Human health EIS knowledge intensive fund: described as the first of its kind approved by HMRC, aimed at early-stage biotech therapeutics and related AI.
  • Human health SEIS fund: backs seed-stage companies working on novel drug discovery, along with enabling services, tools and AI technologies.
  • Seven Sisters Human Health EIS Growth Fund: targets growth-stage UK biotech firms, holding a portfolio of unquoted and AIM-listed companies.

Who it works with

UK biotech and drug-discovery companies, and investors who are high net worth or sophisticated. Prospective investors must self-certify their status before viewing the offers.

Key facts

  • Country: United Kingdom
  • Tax schemes: EIS and SEIS
  • Typical holding period: Investments are usually exited after three years

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-06. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to O2h Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of O2h Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about O2h Ventures.

O2h Ventures alternatives

Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Venture firm investing in deep tech founders who turn scientific discoveries into companies

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Early-stage venture investor in science and technology startups across Europe, now branded Verve Ventures

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

Singapore-headquartered global investment company with a portfolio spread across five sectors